Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Mesothelioma, Malignant 5Hepatoblastoma 3Drug-Related Side Effects and Adverse Reactions 3Central Nervous System Neoplasms 3Ototoxicity 2Oligodendroglioma 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Glioma 2Gastrointestinal Neoplasms 2Astrocytoma 2Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Seminoma 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Lymphoma 1Liver Neoplasms 1Liposarcoma 1

Interventions

Oxaliplatin 18Surveys and Questionnaires 15Fluorouracil 15Capecitabine 13Leucovorin 12Blood Specimen Collection 11Irinotecan 10Standard of Care 7Cisplatin 7Endoscopic Mucosal Resection 6atezolizumab 5Specimen Handling 5Radiotherapy 5Educational Status 5Drug Therapy 5Docetaxel 5S 1 (combination) 4Radiosurgery 4Nivolumab 4Magnetic Resonance Spectroscopy 4Interviews as Topic 4Gemcitabine 4Everolimus 4Colonoscopy 4Biopsy 4Bevacizumab 4tegafur-gimeracil-oteracil 3pemigatinib 3apatinib 3Remote Patient Monitoring 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Neoplasms × sodium thiosulfate × Clear all
NCT05232357 2022-03-15

Endoscopic Vital Nerve Staining in Gastrointestinal Diseases

Affiliated Hospital to Academy of Military Medical Sciences

Phase EARLY_PHASE1 Unknown
100 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT02092298 2021-06-15

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
21 enrolled 7 charts
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡